scientific-skills/venue-templates/references/venue_writing_styles.md
This guide provides an overview of how writing style varies across publication venues. Understanding these differences is essential for crafting papers that read like authentic publications at each venue.
Last Updated: 2024
Scientific writing style exists on a spectrum from broadly accessible to deeply technical:
Accessible ◄─────────────────────────────────────────────► Technical
Nature/Science PNAS Cell IEEE Trans NeurIPS Specialized
│ │ │ │ │ Journals
│ │ │ │ │ │
▼ ▼ ▼ ▼ ▼ ▼
General Mixed Deep Field Dense ML Expert
audience depth biology experts researchers only
| Venue Type | Audience | Tone | Voice | Abstract Style |
|---|---|---|---|---|
| Nature/Science | Educated non-specialists | Accessible, engaging | Active, first-person OK | Flowing paragraphs, no jargon |
| Cell Press | Biologists | Mechanistic, precise | Mixed | Summary + eTOC blurb + Highlights |
| Medical (NEJM/Lancet) | Clinicians | Evidence-focused | Formal | Structured (Background/Methods/Results/Conclusions) |
| PLOS/BMC | Researchers | Standard academic | Neutral | IMRaD structured or flowing |
| IEEE/ACM | Engineers/CS | Technical | Passive common | Concise, technical |
| ML Conferences | ML researchers | Dense technical | Mixed | Numbers upfront, key results |
| NLP Conferences | NLP researchers | Technical | Varied | Task-focused, benchmarks |
High-impact multidisciplinary journals prioritize broad significance over technical depth. The question is not "Is this technically sound?" but "Why should a scientist outside this field care?"
Nature/Science vs. Specialized Journals:
| Element | Nature/Science | Specialized Journal |
|---|---|---|
| Introduction | 3-4 paragraphs, broad → specific | Extensive literature review |
| Methods | Often in supplement or brief | Full detail in main text |
| Results | Organized by finding/story | Organized by experiment |
| Discussion | Implications first, then caveats | Detailed comparison to literature |
| Figures | Conceptual schematics valued | Raw data emphasized |
Nature style:
"We discovered that protein X acts as a molecular switch controlling cell fate decisions during development, resolving a longstanding question about how stem cells choose their destiny."
Specialized journal style:
"Using CRISPR-Cas9 knockout in murine embryonic stem cells (mESCs), we demonstrate that protein X (encoded by gene ABC1) regulates the expression of pluripotency factors Oct4, Sox2, and Nanog through direct promoter binding, as confirmed by ChIP-seq analysis (n=3 biological replicates, FDR < 0.05)."
Medical journals prioritize clinical relevance and patient outcomes. Every finding must connect to practice.
Background: [1-2 sentences on problem and rationale]
Methods: [Study design, setting, participants, intervention, outcomes, analysis]
Results: [Primary outcome with confidence intervals, secondary outcomes, adverse events]
Conclusions: [Clinical implications, limitations acknowledged]
| Study Design | Appropriate Language |
|---|---|
| RCT | "Treatment X reduced mortality by..." |
| Observational | "Treatment X was associated with reduced mortality..." |
| Case series | "These findings suggest that treatment X may..." |
| Case report | "This case illustrates that treatment X can..." |
ML conferences value novelty, rigorous experiments, and reproducibility. The focus is on advancing the state of the art with empirical evidence.
[Paragraph 1: Problem motivation - why this matters]
[Paragraph 2: Limitations of existing approaches]
[Paragraph 3: Our approach at high level]
Our contributions are as follows:
• We propose [method name], a novel approach to [problem] that [key innovation].
• We provide theoretical analysis showing [guarantees/properties].
• We demonstrate state-of-the-art results on [benchmarks], improving over [baseline] by [X%].
• We release code and models at [anonymous URL for review].
ML abstracts are dense and numbers-focused:
"We present TransformerX, a novel architecture for long-range sequence modeling that achieves O(n log n) complexity while maintaining expressivity. On the Long Range Arena benchmark, TransformerX achieves 86.2% average accuracy, outperforming Transformer (65.4%) and Performer (78.1%). On language modeling, TransformerX matches GPT-2 perplexity (18.4) using 40% fewer parameters. We provide theoretical analysis showing TransformerX can approximate any continuous sequence-to-sequence function."
When converting a journal paper to conference format:
When expanding a conference paper to journal:
When targeting Nature/Science/Cell from a specialized venue:
| Venue | Preference | Example |
|---|---|---|
| Nature/Science | Active encouraged | "We discovered that..." |
| Cell | Mixed | "Our results demonstrate..." |
| Medical | Passive common | "Patients were randomized to..." |
| IEEE | Passive traditional | "The algorithm was implemented..." |
| ML Conferences | Active preferred | "We propose a method that..." |
| Venue | First Person | Example |
|---|---|---|
| Nature/Science | Yes (we) | "We show that..." |
| Cell | Yes (we) | "We found that..." |
| Medical | Sometimes | "We conducted a trial..." |
| IEEE | Less common | Prefer "This paper presents..." |
| ML Conferences | Yes (we) | "We introduce..." |
| Claim Strength | Language |
|---|---|
| Strong | "X causes Y" (only with causal evidence) |
| Moderate | "X is associated with Y" / "X leads to Y" |
| Tentative | "X may contribute to Y" / "X suggests that..." |
| Speculative | "It is possible that X..." / "One interpretation is..." |
❌ Too technical: "We used CRISPR-Cas9 with sgRNAs targeting exon 3..." ✅ Accessible: "Using gene-editing technology, we disabled the gene..."
❌ Dry opening: "Protein X is involved in cellular signaling..." ✅ Engaging opening: "How do cells decide their fate? We discovered that..."
❌ Vague contributions: "We present a new method for X" ✅ Specific contributions: "We propose Method Y that achieves Z% improvement on benchmark W"
❌ Missing ablations: Only showing full method results ✅ Complete: Table showing contribution of each component
❌ Missing absolute numbers: "50% reduction in risk" ✅ Complete: "50% relative reduction (ARR 2.5%, NNT 40)"
❌ Causal language for observational data: "Treatment caused improvement" ✅ Appropriate: "Treatment was associated with improvement"
nature_science_style.md - Detailed Nature/Science writing guidecell_press_style.md - Cell family journal conventionsmedical_journal_styles.md - NEJM, Lancet, JAMA, BMJ guideml_conference_style.md - NeurIPS, ICML, ICLR, CVPR conventionscs_conference_style.md - ACL, CHI, SIGKDD guidereviewer_expectations.md - What reviewers look for by venue